Panagora Asset Management’s Precigen PGEN Stock Holding History

Panagora Asset Management’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-155,590	Closed	-$246K	–	1248
2024 Q2	$246K	Sell	155,590 -623	-0.4%	-$905	﹤0.01%	1090
2024 Q1	$227K	Sell	156,213 -147,172	-49%	-$211K	﹤0.01%	1131
2023 Q4	$407K	Buy	+303,385	New	+$356K	﹤0.01%	1038
2018 Q2	–	Sell	-5,194	Closed	-$80K	–	2405
2018 Q1	$80K	Buy	+5,194	New	+$74.3K	﹤0.01%	1901
2015 Q4	–	Sell	-7,414	Closed	-$234K	–	2345
2015 Q3	$234K	Buy	+7,414	New	+$362K	﹤0.01%	1558
2014 Q4	–	Sell	-1,689	Closed	-$30K	–	2329
2014 Q3	$30K	Buy	+1,689	New	+$34.5K	﹤0.01%	2106
2014 Q1	–	Sell	-93,389	Closed	-$2.12M	–	2362
2013 Q4	$2.12M	Buy	93,389 +1,911	+2%	+$38.6K	0.01%	839
2013 Q3	$2.07M	Buy	+91,478	New	+$2.11M	0.01%	806

Other funds holding PGEN

PCM

Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Panagora Asset Management's PGEN Position: Q3 2024 in Review

Panagora Asset Management sold out of Precigen (PGEN) in Q3 2024, closing a stake of 155,590 shares — an estimated $246K sold.

Panagora Asset Management first reported a position in PGEN in Q3 2013 and held it in 8 quarters. The position peaked at $2.12M in Q4 2013. 127 funds tracked by Wall St. Rank hold PGEN as of Q3 2024.

Panagora Asset Management reported no remaining Precigen position as of Q3 2024 after selling out during the quarter.
Panagora Asset Management sold 155,590 Precigen shares in Q3 2024, an estimated $246K.
Panagora Asset Management first reported a position in Precigen in Q3 2013 and held it in 8 quarters.
Panagora Asset Management's Precigen position peaked at $2.12M in Q4 2013.
127 funds tracked by Wall St. Rank held Precigen as of Q3 2024.

Based on Panagora Asset Management's 13F filing for Q3 2024, filed 13 Nov 2024.